Literature DB >> 7093954

Formation of the cross-link 1-[N3-deoxycytidyl),2-[N1-deoxyguanosinyl]ethane in DNA treated with N,N'-bis(2-chloroethyl)-N-nitrosourea.

W P Tong, M C Kirk, D B Ludlum.   

Abstract

The cross-linked dinucleoside, 1-[N3-deoxycytidyl],2-[N1-deoxyguanosinyl]ethane, has been isolated from DNA which has been exposed to N,N'-bis(2-chloroethyl)-N-nitrosourea. It is probable that this structure is responsible for the interstrand cross-linking observed previously by physical methods. The modification is unique in that it cross-links DNA through two base-pairing positions and probably arises through the transfer of a chloroethyl group to one of the bases followed by a second reaction of this group with the other strand of DNA. Initial attack could be at the N3 position of deoxycytidine, the N1 position of deoxyguanosine, or possibly the O6 position of deoxyguanosine. Attack at the O6 position of deoxyguanosine would require an internal cyclization with the N1 position of deoxyguanosine before secondary reaction with the N3 position of deoxycytidine but would explain resistance to N,N'-bis(2-chloroethyl)-N-nitrosourea in cells capable of removing substituents on the O6 position of guanine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7093954

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  A rapid survival assay to measure drug-induced cytotoxicity and cell cycle effects.

Authors:  Chandni Valiathan; Jose L McFaline; Leona D Samson
Journal:  DNA Repair (Amst)       Date:  2011-11-30

2.  Cross-link structure affects replication-independent DNA interstrand cross-link repair in mammalian cells.

Authors:  Erica M Hlavin; Michael B Smeaton; Anne M Noronha; Christopher J Wilds; Paul S Miller
Journal:  Biochemistry       Date:  2010-05-11       Impact factor: 3.162

3.  Alleviation of 1,N6-ethanoadenine genotoxicity by the Escherichia coli adaptive response protein AlkB.

Authors:  Lauren E Frick; James C Delaney; Cintyu Wong; Catherine L Drennan; John M Essigmann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-09       Impact factor: 11.205

4.  Cross-linking of DNA induced by chloroethylnitrosourea is presented by O6-methylguanine-DNA methyltransferase.

Authors:  P Robins; A L Harris; I Goldsmith; T Lindahl
Journal:  Nucleic Acids Res       Date:  1983-11-25       Impact factor: 16.971

5.  Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanine.

Authors:  M E Dolan; G L Larkin; H F English; A E Pegg
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 6.  DNA adducts and DNA damage by antineoplastic and carcinogenic N-nitrosocompounds.

Authors:  G Eisenbrand; N Müller; E Denkel; W Sterzel
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme.

Authors:  Jeffrey J Olson; Ellen McKenzie; Megan Skurski-Martin; Zhaobin Zhang; Daniel Brat; Surasak Phuphanich
Journal:  J Neurooncol       Date:  2008-08-05       Impact factor: 4.130

8.  Increased cytotoxicity of 1-(2-chloroethyl)-1-nitroso-3(4-methyl)-cyclohexylurea by pretreatment with O6-methylguanine in resistant but not in sensitive human melanoma cells.

Authors:  W Dempke; P Nehls; U Wandl; D Soll; C G Schmidt; R Osieka
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

9.  The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.

Authors:  P Bedford; M R Berger; G Eisenbrand; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

10.  Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53.

Authors:  S C Naumann; W P Roos; E Jöst; C Belohlavek; V Lennerz; C W Schmidt; M Christmann; B Kaina
Journal:  Br J Cancer       Date:  2009-01-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.